Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations
Files
(Published version)
Date
2023
Authors
Langford, A.V.
Lin, C.C.W.
Bero, L.
Blyth, F.M.
Doctor, J.
Holliday, S.
Jeon, Y.H.
Moullin, J.
Murnion, B.
Nielsen, S.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Medical Journal of Australia, 2023; 219(2):80-88
Statement of Responsibility
Conference Name
Abstract
Long term opioids are commonly prescribed to manage pain. Dose reduction or discontinuation (deprescribing) can be challenging, even when the potential harms of continuation outweigh the perceived benefits. The Evidence-based clinical practice guideline for deprescribing opioid analgesics was developed using robust guideline development processes and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology, and contains deprescribing recommendations for adults prescribed opioids for pain.
School/Discipline
Dissertation Note
Provenance
Description
Data source: Supplementary information, https://doi.org/10.5694/mja2.52002
Access Status
Rights
Copyright 2023 The Authors. Medical Journal of Australia published by John Wiley & Sons Australia, Ltd on behalf of AMPCo Pty Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made